Tackling Drug Shortages in Hematologic Oncology Care Requires Nuance and Adaptability

Drug shortages have touched nearly every area of cancer care throughout the years, but their effects can be particularly felt in hematologic oncology, where certain agents are often needed as backbones of treatment and lymphodepleting regimens. In order to best prepare for these inevitable shortages and to minimize their effect on patient care, oncologists must have suitable alternatives in mind that will not compromise the efficacy and safety of a therapeutic regimen.